英雄横幅 - 图像

TOGETHER, WE'VE GOT THIS.

耐心Can't Wait. Neither Can We.™

学到更多

智能手机的图象

A Transformational Approach to Clinical Trials

Labcorp.Transforms the Clinical Trial Experience to Streamline its Drug Development Process

Company goes beyond decentralized clinical trials to deliver seamless tech-enabled, patient-centric enterprise solutions. LabCorp now offers a comprehensive and fully integrated patient, site, and customer experience for DCTs.

一种新的和创新招募肿瘤患者的方法

Covance and Tempus Have Joined Forces to Accelerate Patient Recruitment in Biomarker-Driven Studies

We are expanding our patient-centric approach to recruitment by incorporating the Tempus Integrated Molecular Evaluation (TIME) Trial™ Program. Learn more about how our combined recruitment capabilities can screen and match patients to biomarker trials to open a site in as few as 10 days.

Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

Covance announces acquisition of snapIoT

Labcorp宣布,Covance已完成交易以获取Snapiot,即增长平台最快的平台作为移动连接的自助服务平台解决方案的服务提供商。此次收购使得Covance能够提供高度可配置和可操作可插拔的患者中心解决方案,使远程参与临床试验,可在加速实施和提高数据质量时降低患者负担。

我们在一起

COVID-19

Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the global pandemic.

新闻

Covance Announces Acquisition of GlobalCare Clinical Trials, LLC

Labcorp宣布,Covance已完成交易,以获得全球公认的分散临床试验(DCT)的全球公认的行业领导者。收购GlobalCare将扩大董事会DCTS提供进入全球市场的COT,并帮助我们满足您对患者为中心的试验设计的不断增长的需求。

Covance Innovation

患者等不及了。既不是我们可以

The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease…to improve quality of life. And it’s our mission to help speed that process. What matters is not “how it’s always been done,” but how it can be done now. Better. And Faster. Through new approaches explored, ideas perfected, and transformational thinking.

#covance potential.

这不仅仅是一份工作。对我们来说,它是个性化的。

Covance, the drug development business of LabCorp, is recognized as a leader in drug development because of our exceptional people. We embrace and celebrate the different strengths, experiences and perspectives of our 65,000+ enterprise team members across the globe. Our team is driven by an energizing purpose to improve health and improve lives. Here, you can play a role in bringing new scientific discoveries to life and make a difference in the lives of millions. Join us and discover your extraordinary potential.

Covance by the Numbers

年度遭遇 160M 耐心
Supports Clinical Trials in 100+ 国家
合作 100% 新型肿瘤药物
帮助发展 86% 罕见的孤儿药

Contributed in the development of all the current top 50 drugs on the market

Covance Insights

COVID-19: vaccine innovation and safety at pandemic speed
COVID-19: vaccine innovation and safety at pandemic speed
博客s
Covid-19的全球传播及其对人口健康和福祉的影响很大,因此举办了一个以前所未有的速度开发有效疫苗的种族。通常跨越几年的发展过程正在压缩成一年或更少。安全是该过程的重要组成部分,因此我们确定并讨论了疫苗开发中安全的几个关键因素和考虑因素。本文提供了我们见解的概要。
阅读更多
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
Closing the Gap in Pediatric Oncology Drug Development: The Regulatory Landscape and the RACE for Children Act
白皮书
目前的监管环境可以帮助支持儿科肿瘤发起的复杂努力,因为监管机构和立法行为有助于鼓励,激励甚至要求在其他适应症中进行儿科试验。本白皮书提供了小儿癌症治疗进展的简要历史,概述了监管变化如何影响儿科药物开发领域,并为申请当前规定提供指导,例如专注于小儿科肿瘤的儿童行为竞争。这种变化应该有助于提高肿瘤药物发展的包容性监管策略。
阅读更多
医疗设备和诊断解决方案:临床前与实验手术yaboapp体育官网
医疗设备和诊断解决方案:临床前与实验手术yaboapp体育官网
小册子
通过与我们的医疗设备开发专家合作来制yaboapp体育官网作最佳临床前策略。然后访问使您的初始开发阶段更容易yaboapp体育官网所需的临床前资源。无论您是探索有前途的设备概念,启动全面的检测计划或进行单一学习,Covance医疗设备和诊断解决方案都可以帮助您在最早的发展阶段证明您的设备。
阅读更多
成规领域再保险imbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
成规领域再保险imbursement Quadruples Enrollment, Increases Stakeholder Satisfaction
实例探究
前5名制药公司与密码合作,为其自身免疫性输液治疗计划提供现场报销管理(FRM)服务。了解有关Covance如何在促进入学和利益相关者满意度方面发挥着关键作用的更多信息。
阅读更多

及时了解Covance的最新消息

现在订阅

学到更多